SCHEMBL28068055

SCHEMBL28068055

COc1cc2ccnc(-c3ccccc3O)c2cc1Br

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.47
APAF1 O14727 1/20 0.43
TDP2 O95551 1/20 0.43
NSD2 O96028 1/20 0.43
CASP3 P42574 1/20 0.43
PPP1CA P62136 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43
SAE1 Q9UBE0 1/20 0.43
UBA2 Q9UBT2 1/20 0.43
ACHE P22303 2/20 0.42
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
TNF P01375 2/20 0.40
KDM4E B2RXH2 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
TP53 P04637 1/20 0.40
SCN9A Q15858 4/20 0.40
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28068054 0.80 MEN1 (0.48) MAOAAPAF1TDP2NSD2CASP3
SCHEMBL16431665 0.79 APAF1 (0.50) MAOAAPAF1TDP2NSD2CASP3
SCHEMBL8213907 0.74 CYP3A4 (0.51) MAOAAPAF1TDP2NSD2CASP3
SCHEMBL16431829 0.74 APAF1 (0.48) MAOAAPAF1TDP2NSD2CASP3
SCHEMBL9704225 0.74 TRPA1 (0.51) MAOAACHEKMT2AMEN1TNF
SCHEMBL628689 0.73 APAF1 (0.47) MAOAAPAF1TDP2NSD2CASP3
SCHEMBL15049142 0.72 SCN9A (0.37) MAOAAPAF1TDP2NSD2CASP3
SCHEMBL10333393 0.72 KLK7 (0.50) MAOAAPAF1TDP2NSD2CASP3
SCHEMBL16432053 0.72 LMNA (0.42) MAOAAPAF1TDP2NSD2CASP3
SCHEMBL31571273 0.72 CYP1A2 (0.47) MAOAKMT2AKDM4ENPSR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105636953-A 1,4-disubstituted pyridazine derivatives and their use for treating smn-deficiency-related conditions NOVARTIS AG 2016-06-01 CN disclosed